TY - JOUR T1 - Cohort profile: the Swiss Cerebral Palsy Registry (Swiss-CP-Reg) cohort study JF - medRxiv DO - 10.1101/2021.11.02.21265824 SP - 2021.11.02.21265824 AU - Fabiën N. Belle AU - Sandra Hunziker AU - Joël Fluss AU - Sebastian Grunt AU - Stephanie Juenemann AU - Christoph Kuenzle AU - Andreas Meyer-Heim AU - Christopher J. Newman AU - Gian Paolo Ramelli AU - Peter Weber AU - Claudia E. Kuehni AU - Anne Tscherter Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/11/05/2021.11.02.21265824.abstract N2 - BACKGROUND Cerebral Palsy (CP) is a group of permanent disorders of movement and posture that follows injuries to the developing brain. It results in motor dysfunction and a wide variety of comorbidities like epilepsy, pain, speech, hearing and vision disorders, cognitive dysfunction, and eating and digestive difficulties. Central data collection is essential to study the epidemiology, clinical presentations, care, and quality of life of patients affected by CP. CP specialists founded the Swiss Cerebral Palsy Registry (Swiss-CP-Reg) in 2017. This paper describes the design, structure, aims and achievements of the Swiss-CP-Reg and presents first results.METHODS Swiss-CP-Reg records patients of any age suffering from CP who are born, treated, or live in Switzerland. It collects data from medical records and reports, from questionnaires answered by patients and their families, and from data linkage with routine statistics and other registries. The registry contains information on diagnosis, clinical presentation, comorbidities, therapies, personal information, family history, and quality of life.Results From August 2017 to August 2021, 546 participants (55% males, mean age at registration 8 years (interquartile range [IQR]: 5-12) were enrolled in Swiss-CP-Reg. Most had been born at term (56%), were less than 2 years old at diagnosis (73%, median 9 months, IQR: 18-25), and were diagnosed with spastic CP (76%). Most (59%) live with a mild motor impairment (Gross Motor Function Classification System [GMFCS] level I or II), 12% with a moderate motor impairment (GMFCS level III), and 29% with a severe motor impairment (GMFCS level IV or V). In a subset of 170 participants, we measured intelligence quotient (IQ) and saw a reduced IQ by GMFCS scale increase. The Swiss-CP-Reg has a strong interest in research with currently 5 nested projects running, and many more planned.CONCLUSIONS Swiss-CP-Reg collects and exchanges national data on people living with CP to answer clinically relevant questions. Its structure enables retrospective and prospective data collection and knowledge exchange between experts to optimise and standardise treatment and improve the health and quality of life of those diagnosed with CP in Switzerland.ClinicalTrials.gov identifier NCT04992871Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by by several funding bodies that included the Schweizerische Stiftung für das cerebral gelähmte Kind (Stiftung Cerebral), Anna Mueller Grocholski Foundation, Swiss Academy of Childhood Disability (SACD), Hand in Hand Anstalt, Ostschweizer Kinderspital, the ACCENTUS Charitable Foundation (Walter Muggli Fund), and the Children's Research Centre (University Children's Hospital Zurich), Stiftung Cerebral was the main sponsor during the build-up phase of the registry.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Cantonal Ethics Committee of Bern (2017-00873, risk category A, observational study) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript. As the cohort is ongoing, new or updated data is available upon reasonable request to the authors.CFCSCommunication Function Classification SystemCPCerebral PalsyFSOFederal Statistics OfficeGMFCSGross Motor Function Classification SystemISPMInstitute of Social and Preventive MedicineIQIntelligence quotientMACSManual Ability Classification SystemREDCapResearch Electronic Data CaptureSACDSwiss Academy of Childhood DisabilitySCPESurveillance of Cerebral Palsy in EuropeSwiss-CP-RegSwiss Cerebral Palsy RegistrySwissNeoNetSwiss Neonatal Network and Follow-up GroupSwissPedNetSwiss Research Network of Clinical Paediatric HubsSwissPedRegSwiss Research Platform for Paediatric Registries ER -